cephalosporin c has been researched along with Atypical Mycobacterial Infection, Disseminated in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA | 1 |
| Cox, JAG; Desai, M; Harrison, J; Lambert, PA; Lopeman, RC; Rathbone, DL | 1 |
| Alves, CN; Bailey, S; Chauhan, V; Cohen, KA; d'Andrea, FB; Freundlich, JS; Ginell, SL; Kumar, P; Lameira, J; Lamichhane, G; Li, SG; Silva, JRA | 1 |
| Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B | 1 |
| Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM | 1 |
| Hashimoto, K; Ito, K; Ogata, H | 1 |
| Bansal, AK; Garg, P; Sharma, S; Vemuganti, GK | 1 |
1 review(s) available for cephalosporin c and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Bilateral infectious keratitis after laser in situ keratomileusis: a case report and review of the literature.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cornea; Cyanoacrylates; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection; Visual Acuity | 2001 |
6 other study(ies) available for cephalosporin c and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
T405, a New Penem, Exhibits
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2022 |
Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
Topics: Amoxicillin; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Plasmids | 2020 |
Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
Topics: Anti-Bacterial Agents; Carbapenems; Cell Wall; Cephalosporins; Crystallography, X-Ray; Drug Synergism; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Penicillins; Peptidoglycan; Peptidyl Transferases; Protein Structure, Tertiary | 2017 |
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary | 2003 |